1 / 8

Automated Cell Counters Market it is estimated to grow at a CAGR of 5.9% by 2028

The automated cell counters market is expected to grow from US$ 6,974.29 million in 2021 to US$ 10,365.95 million by 2028; it is estimated to grow at a CAGR of 5.9% from 2022 to 2028.<br><br>For more info..<br>https://www.theinsightpartners.com/reports/automated-cell-counters-market/<br>?utm_source=freeplatform&utm_medium=10726

Sanket15
Download Presentation

Automated Cell Counters Market it is estimated to grow at a CAGR of 5.9% by 2028

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Automated Cell Counters Market Global Analysis and Forecast to 2028 Published Date : Jul 2022 Email: sales@theinsightpartners.com

  2. Email:sales@theinsightpartners.com Report Studies • Automated Cell Counters Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Hematocytometers, Flow Cytometers, Electrical Impedance Coulter Counter, and Spectrophotometers) and End User (Hospitals, Research Laboratories, Diagnostic Centers, and Others)

  3. Email:sales@theinsightpartners.com Automated Cell Counters Market Value CAGR of 5.9% (2022 - 2028)

  4. Email:sales@theinsightpartners.com Automated Cell Counters Market Overview • The automated cell counters market is expected to grow from US$ 6,974.29 million in 2021 to US$ 10,365.95 million by 2028; it is estimated to grow at a CAGR of 5.9% from 2022 to 2028. • According to World Health Organization (WHO), 41 million people die yearly due to chronic diseases, equivalent to 71% of all deaths globally. As per the Centers for Disease Control and Prevention (CDC), six in ten adults in the US have a chronic disease, and four in ten adults have two or more chronic diseases. According to Cancer Research UK, ~17 million new cases of cancer were detected worldwide in 2018. Further, in 2018, ~9.6 million deaths occurred due to cancer worldwide. Diagnostics are essential in determining the direction of any medical treatment of infectious and chronic diseases. Cell counting is one of the methods that is used for the detection of such diseases. Therefore, the rising prevalence of infectious and chronic diseases across the globe is driving the growth of the automated cell counters market.

  5. Email:sales@theinsightpartners.com Key Segment Market Segment By Type:- • By Type (Hematocytometers, Flow Cytometers, Electrical Impedance Coulter Counter, and Spectrophotometers) • By End User (Hospitals, Research Laboratories, Diagnostic Centers, and Others)

  6. Email:sales@theinsightpartners.com Company Profiles • Eppendorf • Thermo Fischer Scientific • Countstar, Inc. • Bio-Rad Laboratories, Inc. • F. Hoffmann-La Roche Ltd • Chemometec A/S • ALIGNEDGENETICS • Beckman Coulter, Inc. (Danaher) • Nanoentek • Olympus Corporation • MERCK KGaA Download Sample Here

  7. Email:sales@theinsightpartners.com By Geography • North America (the US, Canada, and Mexico) • Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) • Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) • Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) • South & Central America (Brazil, Argentina, and the Rest of South & Central America).

  8. THANKYOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com

More Related